Become A Featured Company

Emerald Health: Transformational Joint Venture with Best-in-Class Greenhouse Grower to Lead Industry with Low Cost Production

Ryan Allway

June 13th, 2017

News, Top News

The Canadian cannabis industry is projected to reach up to C$22.6 billion over the coming years as recreational legalization goes into effect next year. Despite the enormous interest in the space, the market is expected to experience a supply shortfall through 2020 as producers ramp up production. This has created an opportunity for existing licensed producers to scale up production to generate incremental revenue.

In this article, we will look at Emerald Health Therapeutics Inc.’s (TSX-V: EMH) (OTCQX: TBQBF) new 50-50 joint venture with Village Farms International Inc. (TSX: VFF) (OTCQX: VFFIF), designed to enable large-scale, high-quality, and low-cost cannabis production.

Scaling Production

Under terms of the agreement, Village Farms has contributed a 1.1 million square foot greenhouse facility located on a 50-acre parcel of land in Delta, British Columbia. Emerald Health will contribute a total of C$20 million in cash to fund the conversion of the greenhouse into an ACMPR-approved facility.

Village Farms is one of the most experienced greenhouse growers in North America with a combined 750 years of experience on its team. With 1.1 million square feet of production, the facility could produce more than 75,000 kilograms of cannabis each year upon full licensing and conversion. The JV also has the option to acquire up to 3.7 million square feet of additional greenhouse capacity. In aggregate these facilities could allow production upwards of 300,000 kilograms per year.

The deal provides Emerald Health with a low-cost and low-risk way to scale up its production and optimize raw material supply for downstream product development. While most of its peers are focused on new-builds to scale up, Emerald has now partnered with an established operator to rapidly scale without much of the associated execution risk that many of its peers likely face. The joint venture plans to focus its efforts on extraction-based products targeting the recreational marijuana market that’s due to come into effect next year.

The company also continues to advance its 32-acre Lower Mainland, British Columbia facility that will house an initial 50,000 square feet. This indoor facility will remain focused on growing high-quality and unique genetics along with housing lab, research facility, processing, and other associated infrastructure for downstream product development.

Filling the Production Gap

Canada’s cannabis industry is expected to reach up to C$22.6 billion in size over the coming years, according to Deloitte Canada, driven by the legalization of recreational marijuana next year. The retail market could be worth between C$4.9 billion and C$8.7 billion per year, while cultivation, processing, testing, and other services would make up for the difference and yield a market that could reach C$12.7 billion to C$22.6 billion.

With a limited number of licensed producers, many analysts believe that there could be a shortfall of supply as cultivators ramp up production. PI Financial projects that licensed producers would have to cultivate a total of 610,000 kilograms of cannabis to fulfill domestic demand by 2019, but existing capacity could lead to a 200,000 kilogram shortfall. This could lead to significant growth opportunities for licensed producers looking to expand.

Emerald Health believes that its agreement with Village Farms could help close much of that production shortfall if its facility is approved. With an initial 75,000 kilograms per year of production coming online, the company could make a big dent early on before potentially increasing that production to 300,000 kilograms if it exercises certain options. This could in turn create a windfall for the company’s shareholders.

Looking Ahead

Emerald Health Therapeutics Inc. (TSX-V: EMH)(OTCQX: TBQBF) is uniquely positioned within Canada’s burgeoning cannabis industry. With its new joint venture, the company aims to help close the production gap that could impact the industry, while generating significantly more revenue for the company. Investors interested in the space may want to take a closer look at the stock as it seeks to gain approvals for the new joint venture facility.

For more information, visit the company’s website at http://www.emeraldhealth.ca/.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading